|
1
|
Adams JM: Ways of dying: multiple pathways
to apoptosis. Genes Dev. 17:2481–2495. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thompson CB: Apoptosis in the pathogenesis
and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bidere N, Su HC and Lenardo MJ: Genetic
disorders of programmed cell death in the immune system. Annu Rev
Immunol. 24:321–352. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong RBY: Apoptosis in cancer: from
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McDonnell TJ, Troncoso P, Brisbay SM,
Logothetis C, Chung LW, Hsieh JT, et al: Expression of the
protooncogene BCL-2 in the prostate and its association with
emergence of androgen-independent prostate cancer. Cancer Res.
52:6940–6944. 1992.PubMed/NCBI
|
|
8
|
Raffo AJ, Perlman H, Chen MW, Day ML,
Streitman JS and Buttyan R: Overexpression of BCL-2 protects
prostate cancer cells from apoptosis in vitro and confers
resistance to androgen depletion in vivo. Cancer Res. 55:4438–4445.
1995.PubMed/NCBI
|
|
9
|
McConkey DJ, Greene G and Pettaway CA:
Apoptosis resistance increase with metastatic potential in cells of
the human LNCaP prostate carcinoma line. Cancer Res. 56:5594–5599.
1996.PubMed/NCBI
|
|
10
|
Fuzio P, Ditonno P, Lucarelli G, Battaglia
M, Bettocchi C, Senia T and Perlino E: Androgen deprivation therapy
affects BCL-2 expression in human prostate cancer. Int J Oncol.
39:1233–1242. 2011.PubMed/NCBI
|
|
11
|
Yoshino T, Shiina H, Urakami S, Kikuno N,
Yoneda T, Shigeno K and Igawa M: Bcl-2 expression as a predictive
marker of hormone-refractory prostate cancer treated with
taxane-based chemotherapy. Clin Cancer Res. 12:6116–6124. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geula S, Ben-hail D and Shoshan-Barmartz
V: Structure-based analysis of VDAC1: N-terminus location,
translocation, channel gating and association with anti-apoptotic
protein. Biochem J. 444:475–485. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Messina A, Reina S, Guarino F and De Pinto
V: VDAC isoforms in mammals. Biochim Biophys Act. 1818:1466–1476.
2012. View Article : Google Scholar
|
|
14
|
Shimizu S, Matsuoka Y, Shinohara Y, Yoneda
Y and Tsujimoto Y: Essential role of voltage-dependent anion
channel in various forms of apoptosis in mammalian cells. J Cell
Biol. 152:237–250. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shore GC: Apoptosis: it’s Bak to VDAC.
EMBO Rep. 10:1311–1313. 2009.
|
|
16
|
Abu-Hamad S, Arbel N, Calo D, Arzoine L,
Israelson A, Keinan N, Ben-Romano R, Friedman O and Shoshan-Barmatz
V: The VDAC1 N-terminus is essential both for apoptosis and the
protective effect of anti-apoptotic proteins. J Cell Sci.
122:1906–1916. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bellot G, Cartron PF, Er E, Oliver L, Juin
P, Armstrong LC, Bornstein P, Mihara K, Manon S and Vallette FM:
TOM22, a core component of the mitochondria outer membrane protein
translocation pore, is a mitochondrial receptor for the
proapoptotic protein Bax. Cell Death Differ. 14:785–794. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ott M, Norberg E, Zhivotovsky B and
Orrenius S: Mitochondrial targeting of tBid/Bax: a role for the TOM
complex? Cell Death Differ. 16:1075–1078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cassará MC, Menzel VA, Hinsch KD,
Wrenzycki C and Hinsch E: Voltage-dependent anion channels 1 and 2
are expressed in porcine oocytes. Biosci Rep. 30:193–200.
2009.PubMed/NCBI
|
|
20
|
Vandesompele J, De Preter K, Pattyn F,
Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate
normalization of the real-time quantitative RT-PCR data by
geometric averaging of multiple internal control genes. Genome
Biol. 3:RESEARCH00342002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Catz SD and Johnson JL: Bcl-2 in prostate
cancer: a minireview. Apoptosis. 8:29–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lemelynova AA, Grygorenko VM, Cheremuha SV
and Romanenko АМ: Correlation between histological type and
immunohistochemical profile of prostate cancer and Gleason scale
gradation. J Exp Oncol. 31:246–249. 2009.PubMed/NCBI
|
|
23
|
Hockenbery DM, Zutter M, Hickey W, Nahm M
and Korsmeyer SJ: Bcl2 protein is topographically restricted in
tissues characterized by apoptotic cell death. Proc Natl Acad Sci
USA. 88:6961–6965. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Motz C, Martin H, Krimmer T and Rassow J:
Bcl-2 and porin follow different pathways of TOM-dependent
insertion into the mitochondrial outer membrane. J Mol Biol.
323:729–738. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ross K, Rudel T and Kozjak-Pavlovic V:
TOM-independent complex formation of Bax and Bak in mammalian
mitochondria during TNFalpha-induced apoptosis. Cell Death Differ.
16:697–707. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schein SJ, Colombini M and Finkelstein A:
Reconstitution in planar lipid bilayers of a voltage-dependent
anion-selective channel obtained from Paramecium
mitochondria. J Membr Biol. 30:99–120. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benz R: Permeation of hydrophilic solutes
through mitochondrial outer membranes: review on mitochondrial
porins. Biochim Biophys Acta. 1197:167–196. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thinnes FP: Evidence for
extra-mitochondrial localization of the VDAC/porin channel in
eukaryotic cells. J Bioenerg Biomembr. 24:71–75. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Pinto V, Messina A, Lane DJ and Lawen
A: Voltage-dependent anion-selective channel (VDAC) in the plasma
membrane. FEBS Lett. 584:1793–1799. 2010.
|
|
30
|
Shoshan-Barmatz V and Mizrachi D: VDAC1:
from structure to cancer therapy. Front Oncol. 2:1642012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Simamura E, Hirai K, Shimada H, Koyama J,
Niwa Y and Shimizu S: Furanonaphthoquinones cause apoptosis of
cancer cells by inducing the production of reactive oxygen species
by the mitochondrial voltage-dependent anion channel. Cancer Biol
Ther. 5:1523–1529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hastie C, Saxton M, Akpan A, Cramer R,
Master JR and Naaby-Hansen S: Combined affinity labeling and mass
spectrometry analysis of differential cell surface protein
expression in normal and prostate cancer cells. Oncogene.
24:5905–5913. 2005. View Article : Google Scholar
|
|
33
|
Jiang N, Kham SK, Koh GS, Suang Lim JY,
Ariffin H, Chew FT and Yeoh AE: Identification of prognostic
protein biomarkers in childhood acute lymphoblastic leukemia (ALL).
J Proteomics. 74:843–857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Castagna A, Antonioli P, Astner H, Hamdan
M, Righetti SC, Perego P, Zunino F and Righetti PG: A proteomic
approach to cisplatin resistance in the cervix squamous cell
carcinoma cell line A431. Proteomics. 4:3246–3267. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nawarak J, Huang-Liu R, Kao SH, Liao HH,
Sinchaikul S, Chen ST and Cheng SL: Proteomic analysis of A375
human malignant melanoma cells in response to arbutin treatment.
Biochim Biophys Acta. 1792:159–167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lai JC, Tan W, Benimetskaya L, Miller P,
Colombini M and Stein CA: A pharmacologic target of G3139 in
melanoma cells may be the mitochondrial VDAC. Proc Natl Acad Sci
USA. 103:7494–7499. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thinnes FP: Neuroendocrine differentiation
of LNcaP cells suggests: VDAC in the cell membrane is involved in
the extrinsic apoptotic pathway. Mol Genet Metab. 97:241–243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shoshan-Barmatz V, Keinan N and Zaid H:
Uncovering the role of VDAC in the regulation of cell life and
death. J Bioenerg Biomembr. 40:183–191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Abu-Hamad S, Sivan S and Shoshan-Barmatz
V: The expression level of the voltage-dependent anion channel
controls life and death of the cell. Proc Natl Acad Sci USA.
103:5787–5792. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rostovtseva T and Colombini M: VDAC
channels mediate and gate the flow of ATP: implications for the
regulation of mitochondrial function. Biophys J. 72:1954–1962.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tan W and Colombini M: VDAC closure
increases calcium ion flux. Biochim Biophys Acta. 1768:2510–2515.
2007. View Article : Google Scholar : PubMed/NCBI
|
